Lidocaine-A Promising Candidate for the Treatment of Cancer-Induced Bone Pain: A Narrative Review
- PMID: 40232625
- DOI: 10.1007/s12325-025-03192-w
Lidocaine-A Promising Candidate for the Treatment of Cancer-Induced Bone Pain: A Narrative Review
Abstract
Pain is one of the most common symptoms in patients with cancer, with cancer-induced bone pain (CIBP) significantly affecting their quality of life. Opioids are commonly used as first-line treatments for cancer pain, but their use requires caution due to non-mechanistic analgesia and significant side effects. As a result, there is a need for new non-opioid drugs that target cancer pain through specific mechanisms. Recent studies on the anticancer effects of lidocaine have highlighted its potential benefits in both treating cancer and alleviating cancer-induced pain. This article discusses the mechanism of action and clinical applications of lidocaine in cancer pain management, and suggests new treatment approaches for patients with CIBP.
Keywords: Cancer-induced bone pain; Lidocaine; Pain management.
© 2025. The Author(s), under exclusive licence to Springer Healthcare Ltd., part of Springer Nature.
Conflict of interest statement
Declarations. Conflict of Interest: Lihan Luo, Yuqi Cheng, Hanxi Wang, Li Li, Hanyun Niu, Yuzhu Yang, Qianqian Zhou, Jiannan He, and Jianhong Xu have nothing to disclose. Ethical Approval: This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors.
References
-
- Siegel RL, Giaquinto AN, Jemal A. Cancer statistics, 2024. CA A Cancer J Clin. 2024;74:12–49. - DOI
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials